IN8bio【INAB】株式ニュース

名称	銘柄コード	市場	種別
IN8bio Inc	INAB	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.0198	-1.96%	0.9902	09:00:00

始値	安値	高値	終値	前日終値
1.00	0.9837	1.0199	0.9902	1.01

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/10	05:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/10	05:04	EDGAR2	Form 8-K - Current report
2024/5/10	05:00	GLOBE	IN8bio Reports First Quarter 2024 Financial Results and..
2024/5/08	05:05	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/4/30	19:05	GLOBE	IN8bio Doses First Patient in Phase 2 Clinical Trial of..
2024/4/24	21:00	GLOBE	IN8bio Announces Oral Presentation at the Upcoming American..
2024/4/17	05:05	GLOBE	IN8bio to Present at Noble Capital Markets Emerging Growth..
2024/4/10	05:30	GLOBE	IN8bio Announces New Preclinical Data for Gamma-Delta..
2024/3/15	05:00	GLOBE	IN8bio Reports Fourth Quarter and Full-Year 2023 Financial..
2024/3/06	06:30	GLOBE	IN8bio to Present New Preclinical Data on Novel Gamma-Delta..
2024/2/26	22:00	BW	IN8bio to Present at Upcoming Investor Conferences
2024/2/14	22:00	GLOBE	IN8bio Announces Publication on Novel Gamma-Delta T Cell..
2024/2/09	06:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/09	06:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/09	06:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/09	06:49	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/09	06:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/09	06:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/20	06:06	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2024/1/19	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2024/1/19	06:31	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/1/13	07:16	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2024/1/04	22:00	GLOBE	IN8bio Highlights Recent Company Accomplishments and..
2023/12/16	06:31	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2023/12/15	22:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/15	22:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/15	22:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/15	22:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/15	22:22	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/15	22:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/15	22:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/15	20:02	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2023/12/14	20:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/12	07:15	EDGAR2	Form 8-K - Current report
2023/12/12	06:05	GLOBE	IN8bio Announces Positive Clinical Update Demonstrating..
2023/12/11	23:00	GLOBE	IN8bio Announces Pricing of Financing Totaling up to $46.9..
2023/12/11	22:56	EDGAR2	Form 8-K - Current report
2023/12/09	06:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/09	06:24	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2023/12/08	06:15	EDGAR2	Form 8-K - Current report
2023/12/07	22:00	GLOBE	IN8bio Appoints Dr. Corinne Epperly to Board of Directors
2023/12/05	22:00	GLOBE	IN8bio to Host Investor Call at 8:30 AM ET on Tuesday,..
2023/11/20	23:04	EDGAR2	Form 8-K - Current report
2023/11/20	21:00	GLOBE	IN8bio’s INB-200 Demonstrates Extended Progression-Free..
2023/11/10	21:00	GLOBE	IN8bio to Present Data Highlighting Potential of INB-200 and..
2023/11/10	06:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10	06:03	EDGAR2	Form 8-K - Current report
2023/11/10	06:00	GLOBE	IN8bio Reports Third Quarter 2023 Financial Results and..
2023/11/06	22:00	GLOBE	IN8bio Presents Biologic Correlative Data from the INB-200..
2023/11/04	01:00	GLOBE	IN8bio Presents Positive Data Update from Induced..